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Objectives This study sought to determine the prognostic value of wall motion and perfusion assessment during high-dose
dobutamine stress (DS) cardiac magnetic resonance imaging (MRI) in a large patient cohort.
Background DS-MRI offers the possibility to integrate myocardial perfusion and wall motion analysis in a single examination
for the detection of coronary artery disease (CAD).
Methods A total of 1,493 consecutive patients with suspected or known CAD underwent DS-MRI, using a standard proto-
col in a 1.5-T magnetic resonance scanner. Wall motion and perfusion were assessed at baseline and during
stress, and outcome data including cardiac death, nonfatal myocardial infarction (“hard events”), and “late” re-
vascularization performed 90 days after the MR scans were collected during a 2  1 year follow-up period.
Results Fifty-three hard events, including 14 cardiac deaths and 39 nonfatal infarctions, occurred during the follow-up
period, whereas 85 patients underwent “late” revascularization. Using multivariable regression analysis, an ab-
normal result for wall motion or perfusion during stress yielded the strongest independent prognostic value for
both hard events and late revascularization, clearly surpassing that of clinical and baseline magnetic resonance
parameters (for wall motion: adjusted hazard ratio [HR] of 5.9 [95% confidence interval (CI): 2.5 to 13.6] for
hard events and of 3.1 [95% CI: 1.7 to 5.6] for late revascularization, and for perfusion: adjusted HR of 5.4 [95% CI:
2.3 to 12.9] for hard events and of 6.2 [95% CI: 3.3 to 11.3] for late revascularization, p  0.001 for all).
Conclusions DS-MRI can accurately identify patients who are at increased risk for cardiac death and myocardial infarction,
separating them from those with normal findings, who have very low risk for future cardiac events. (Prognostic
Value of High Dose Dobutamine Stress Magnetic Resonance Imaging; NCT00837005) (J Am Coll Cardiol
2010;56:1225–34) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.06.020a
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figh-dose dobutamine/atropine stress (DS) cardiac mag-
etic resonance imaging (MRI) is incorporated into daily
linical practice for the detection of coronary artery disease
CAD). This technique offers the possibility to integrate
yocardial perfusion and wall motion analysis in a sin-
le examination. In this regard, recent data suggest that the
ssessment of myocardial wall motion and perfusion during
rom the *Department of Cardiology, University of Heidelberg, Heidelberg, Ger-
any; and the †Department of Psychosomatic and General Internal Medicine,
niversity of Heidelberg, Heidelberg, Germany. The authors have reported that they
ave no relationships to disclose.b
Manuscript received November 3, 2009; revised manuscript received April 30,
010, accepted June 15, 2010.single dobutamine stress session may enhance the sensi-
ivity of the technique for ischemia detection (1).
See page 1244
However, to date, limited data are available on the
rognostic value of high-dose DS-MRI in large patient
ohorts receiving optimal medical therapy (2). Assessment
f long-term outcome of DS-MRI is important because this
est may identify both high-risk patients who would benefit
rom invasive diagnostic and therapy, and lower-risk pa-
ients in whom additional procedures and intensive medical
ollow-up are not required.
In the present study, we sought to determine the association
etween DS-MRI findings with future cardiac events in a large
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Stress MRI for Assessment of Outcome October 5, 2010:1225–34patient cohort (n  1,493). Fur-
thermore, the potential comple-
mentary value of perfusion and
wall motion analysis was investi-
gated, and analysis of subgroups
was conducted to evaluate the use-
fulness of DS-MRI in patients
with low, intermediate, and high
pre-test probability for CAD.
Methods
Study population. The study
was conducted in accordance
with the standards of our local
ethics committee. From Decem-
ber 2004 through January 2008,
consecutive patients (n  1,787)
were referred to our institution
for clinically indicated DS-MRI
ue to suspected or known CAD. Written informed con-
ent was obtained from all patients before the magnetic
esonance examination. Patients with nonsinus rhythm,
nstable angina, severe arterial hypertension (200/120
m Hg), moderate or severe valvular disease, and general
ontraindications to MRI (implanted pacemakers or defi-
rillators) were excluded.
A total of 1,784 patients were screened, and diagnostic
tress examinations (positive for ischemia or negative but
ith achievement of 85% of the age-predicted heart
ate) were obtained in 1,510 patients. Reasons for dis-
ontinuation of the stress procedures included claustro-
hobia, large body habitus, arrhythmias, failure to
chieve the target heart rate, and side effects. Further-
ore, during the follow-up period, 17 of 1,510 patients
1.1%) were lost, so that 1,493 patients had complete
tress MRI and follow-up information, and constituted
ur patient population (Fig. 1).
Traditional risk factors for CAD, including advanced
ge (45 years for men, 55 years for women), arterial
ypertension, hyperlipidemia, current or prior smoking,
iabetes mellitus, history of CAD, and a family history of
AD were recorded at the time of imaging. Furthermore,
he total number of cardiovascular risk factors (range 0 to 7)
nd the Duke Clinical Score, which incorporates clinical
resentation of chest pain, age, sex, and atherogenic risk
actors (3) were calculated. Hereby, patients were cate-
orized into a low (30%), intermediate (30% to 70%),
r high (70%) pre-test probability group for CAD, as
eported previously (4). Subsequently, patients were sep-
rated into 2 major groups for further analysis, including
hose with low or intermediate risk for CAD and those
ith high pre-test probability or known CAD. In addi-
ion, renal function, which is a major determinant of
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft
CAD  coronary artery
disease
DS  dobutamine stress
LV  left ventricle
LVEF  left ventricular
ejection fraction
MDRD  Modified Diet in
Renal Disease
MRI  magnetic resonance
imaging
PCI  percutaneous
coronary intervention
WMA  wall motion
abnormalitiesardiac-related outcomes in patients with CAD (5), was palculated using the Modified Diet in Renal Disease
MDRD) equation (6).
ardiovascular MR examination. Patients were examined
n a clinical 1.5-T whole-body MR scanner Achieva system
Philips Medical Systems, Best, the Netherlands) using a
-element cardiac phased-array receiver coil. The 4-, 2-,
nd 3-chamber and 3 short-axis views (apical, mid-
entricular, and basal) were used for wall motion assessment
t baseline and were repeated during each stage of inotropic
timulation. Three identical short-axis views were used for
ssessment of myocardial perfusion at baseline and at peak
tress. Dobutamine was infused intravenously during 3-min
tages, at incremental doses of 10, 20, 30, and 40 g/kg of
ody weight per minute until at least 85% of the age-
redicted heart rate was reached (Online Fig. 1). If, at the
eak dose of dobutamine infusion, the target heart rate was
ot achieved, atropine was administrated in 0.25-mg incre-
ents up to a maximal dose of 2.0 mg. Stress testing was
iscontinued when the target heart rate was achieved, or
hen 1 of the following occurred: new or worsening wall
otion abnormalities (WMA), severe chest pain or dys-
Figure 1 Flow Chart of 1,493 Consecutive Patients Who
Completed High-Dose DS-MRI and Clinical Follow-Up
A total of 1,784 consecutive patients were screened for clinically indicated
dobutamine stress magnetic resonance imaging (DS-MRI), and diagnostic
stress examinations (positive for ischemia or negative but with achievement of
85% of the age-predicted heart rate [HR]) were obtained in 1,510 patients.
During the follow-up period, 17 patients were lost, so that 1,493 patients had
complete stress MRI and follow-up data, and constituted our patient
population.nea, decrease in systolic blood pressure of 40 mm Hg,
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October 5, 2010:1225–34 Stress MRI for Assessment of Outcomeevere arterial hypertension (240/130 mm Hg), or severe
rrhythmias.
INE AND PERFUSION IMAGING. A steady-state free preces-
ion sequence was used to obtain the cine images of the 4-,
-, and 3-chamber views and the 3 short-axis planes (apical,
id-ventricular, and basal) with an 8-mm slice thickness.
or perfusion imaging, a single-shot, segmented k-space,
urbo gradient echo/echo planar imaging sequence was used
ith a 10-mm slice thickness. Images were acquired during
he first pass of 0.05 mmol/kg of body weight gadolinium-
TPA (Magnevist, Bayer, Germany).
NTERPRETATION OF MYOCARDIAL WALL MOTION AND
ERFUSION. For interpretation of wall motion, correspond-
ng rest and peak stress cine images were displayed using
iew Forum software (Philips Medical Systems). Seventeen
yocardial segments were evaluated according to American
eart Association guidelines (7), and wall motion was
raded semiquantitatively using a 3-point scale (0  normal
all motion, 1  hypokinesia, 2  akinesia or dyskinesia)
8–10). Inducible ischemia was considered present in cases
f new or worsening WMA of 1 grade during stress. Both
hort- and long-axis views were considered, and WMA in 1
iew was regarded sufficient for the detection of inducible
schemia. For the evaluation of myocardial perfusion, the
ransmural extent of a perfusion deficit was determined
rom the single dynamic image showing the maximum
xtent of regional hypoenhancement. The transmural extent
f perfusion deficits was evaluated visually (0  no defect;
 1% to 25%; 2  26% to 50%; 3  51% to 75%; and
 76% to 100%) both at baseline and during stress. A
egional worsening of the transmural score during stress by
1 in any segment, which persisted for 5 consecutive
mage frames beyond peak myocardial enhancement of the
emote myocardium, which appeared most normal, was
onsidered indicative of myocardial ischemia. When uncer-
ainty existed, signal intensity curves from a remote myo-
ardial region were derived over time to determine the time
rame of peak myocardial enhancement. Perfusion defects
hat were seen at baseline and did not increase during stress
i.e., fixed defects associated with prior infarction) were not
onsidered. In Online Figure 2, 3 examples are provided of
tudies with: 1) normal findings; 2) a subendocardial induc-
ble perfusion abnormality but without inducible WMA;
nd 3) inducible WMA and perfusion defects.
ollow-up data and definition of study end points. Per-
onnel unaware of the stress results contacted each subject or
n immediate family member, and the date of this contact
as used for calculating the follow-up time duration.
utcome data were collected from a standardized question-
aire and determined from patient interviews at the outpa-
ient clinic or by telephone interviews. Reported clinical
vents were confirmed by review of the corresponding
edical records in our electronic Hospital Information
ystem, contact with the general practitioner, referring
ardiologist, or the treating hospital. Cardiac death and aonfatal myocardial infarction were registered as “hard
vents.” Other events included clinically indicated revascu-
arization by percutaneous coronary intervention (PCI) or
oronary artery bypass graft (CABG). Because the results of
he MR examination may have triggered revascularization
rocedures (thereby altering the subsequent event rate),
early” revascularization procedures within 90 days of MRI
ere not considered (n  158 patients), and patients were
ensored at the time of revascularization.
tatistical analysis. Continuous variables are expressed as
ean  SD, whereas categorical variables are expressed as
roportions. Unpaired Student t tests or repeated-measures
NOVA with Bonferroni correction for multiple compar-
sons were used to compare continuous variables. Group
ifferences between ordinal variables were tested using the
xact Mann-Whitney test, and differences between nominal
ariables were assessed using Fisher exact tests. All tests
ere 2-tailed. In a random sample of 40 studies, wall
otion and perfusion data were independently evaluated by
observers (H.S. and G.K.), and agreement was calculated
sing  statistics. Kaplan-Meier curves were used to
stimate the distribution of cardiac events as a function of
he follow-up duration, and the association of baseline
nd MR findings with outcomes was investigated using
ox proportional hazards models and univariate and
ultivariable procedures. For multivariable analysis,
ombined assessment studies were considered abnormal,
ccording to pre-specified criteria, if either WMA or
erfusion defects were present; and normal if both
odalities yielded normal findings. In order to investi-
ate the complementary value of wall motion and perfu-
ion analysis, the value of WMA for the assessment of
ard events was tested in the presence and absence of
erfusion deficits. Furthermore, subgroup analysis was
onducted in this context in patients with known CAD,
esting WMA, and left ventricular hypertrophy. A
value of 0.05 was considered statistically significant.
esults
utcomes
ata were prospectively collected at least 6 months after
he MR examination (2.0  1.0 years, range 0.5 to 4.0
ears). Fifty-three hard events, including 14 cardiac
eaths and 39 nonfatal myocardial infarctions, occurred
uring the follow-up period. In 158 patients, early
evascularization was performed within 90 days after the
R examination (137 by PCI and 21 by CABG), and 85
atients underwent late revascularization (68 by PCI and
7 by CABG).
The baseline characteristics and hemodynamic data of
atients with (n  53) and without hard events (n  1,440)
re illustrated in Table 1. Furthermore, data including
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Stress MRI for Assessment of Outcome October 5, 2010:1225–34easons for referral and medications are presented according
o pre-test probabilities in Online Table 1.
afety Issues
o myocardial infarctions or fatal complications occurred
uring imaging. Severe side effects requiring the termina-
ion of the study occurred in 15 (1.0%) patients due to
ustained ventricular tachycardia (n  3), ventricular fibril-
ation (n  2), severe hypotension (n  4), and severe
ypertension (n  6). The majority of the patients with
ife-threatening arrhythmias and severe hypotension (7 out
f 9) had severely impaired resting LV function.
nivariate and Multivariable Analyses
y univariate analysis, significant associations were observed
etween several clinical parameters, including renal function
nd stress MRI findings for hard events and late revascu-
arization (Fig. 2).
Using multivariable analysis, renal function and baseline
jection fraction were independently associated with hard
vents, whereas the total number of risk factors was associ-
ted with late revascularization procedures. In both models,
n abnormal result for myocardial wall motion or perfusion
emographic and Baseline MR Data of Patients With and WithoutTable 1 Demographic and Baseline MR Data of Patients With a
Parameters
All Patients
(n  1,493)
Clinical data
Age (yrs) 65 13
Advanced age (45 yrs for men, 55 yrs for women) 1,316 (88%)
Male sex 1,110 (74%)
Body mass index (kg/m2) 26.3 3.7
Arterial hypertension 1,054 (71%)
Hyperlipidemia 794 (53%)
Smoking 273 (18%)
Diabetes mellitus 278 (19%)
MDRD (ml/min/1.73 m2) 76.8 29.3
History of CAD 816 (55%)
Family history 334 (22%)
Total risk factors (range 0–7) 3.2 1.5
Prior PCI 599 (40%)
Prior CABG 180 (12%)
Baseline MR data
LVEF (%) 59.8 11.6
Resting WMA 742 (50%)
Baseline hemodynamics
Mean blood pressure (mm Hg) 93 14
Heart rate (1/min) 65 12
Double product (mm Hg/min) 8,183 2,081
Stress hemodynamics
Mean blood pressure (mm Hg) 112 23
Heart rate (1/min) 135 10
Double product (mm Hg/min) 19,494 4,387
ata are presented as mean  SD or as n (%).
BMI bodymass index; CABG coronary artery bypass graft; CAD coronary artery disease; LVE
CI  percutaneous coronary intervention; WMA  wall motion abnormalities.as most strongly associated with outcome (Fig. 3). hurvival Analysis
omplementary value of wall motion and perfusion
nalysis. Kaplan-Meier curves based on stress MR find-
ngs can be appreciated in Figure 4. The presence of
nducible WMA and perfusion deficits was associated
ith a markedly higher rate of hard events (Figs. 4A and
B) and revascularization procedures (Figs. 4C and 4D).
onversely, patients with normal DS-MRI (n  1,193)
ielded a very low event rate for hard events (1 cardiac
eath; 4 myocardial infarctions) and for revascularization
rocedures over the following 4 years (4 by CABG and
1 by PCI).
The presence of inducible WMA added value to risk
tratification of patients with and without diagnosed induc-
ble perfusion deficits, contributing to significantly poorer
utcome in both cases (blue arrows in Figs. 4E and 4F).
onversely, perfusion deficits added value to the risk strat-
fication only in the absence of inducible WMA (red arrow
n Fig. 4G). In patients with diagnosed inducible WMA on
he other hand, the presence of additional perfusion deficits
ontributed to significantly poorer outcome only in patient
ubgroups with resting WMA, whereas a trend was noted in
his context for subgroups with known CAD and LV
Eventsithout Hard Events
atients Without Hard Events
(n  1,440)
Patients With Hard Events
(n  53) p Value
65 13 71 10 0.001
1,265 (88%) 51 (96%) 0.004
1,064 (74%) 46 (87%) 0.037
26.3 3.7 25.8 3.5 0.274
1,014 (70%) 40 (75%) 0.538
761 (53%) 33 (62%) 0.207
256 (18%) 17 (32%) 0.017
267 (19%) 11 (21%) 0.288
77.4 30.3 64.3 30.8 0.006
779 (54%) 37 (70%) 0.024
321 (22%) 13 (25%) 0.736
3.2 1.5 3.8 1.5 0.004
569 (40%) 30 (57%) 0.015
170 (12%) 10 (19%) 0.131
60.0 11.5 55.6 13.7 0.031
701 (49%) 40 (68%) 0.005
93 14 90 16 0.317
65 12 64 12 0.715
8,185 2,084 8,127 2,008 0.872
113 23 96 19 0.001
135 10 129 7 0.001
19,659 4,433 15,010 3,145 0.001
t ventricular ejection fraction; MDRDModified Diet in Renal Disease; MRmagnetic resonance;Hardnd W
Pypertrophy (red arrows in Fig. 5).
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October 5, 2010:1225–34 Stress MRI for Assessment of Outcomeivision into subgroups. PRE-TEST PROBABILITY FOR CAD.
oth in patients with low or intermediate risk and in those
ith high risk, the presence of inducible WMA was
ssociated with hard events (Figs. 6A and 6B). Furthermore,
he presence of inducible WMA was associated with an equally
dverse outcome in both groups (Fig 6C). Conversely, the
bsence of WMA was associated with excellent hard events–
ree survival (99.5%) only in the patients with low or
ntermediate risk, whereas patients without WMA but high
isk still showed a significant number of subsequent hard
vents during follow-up (5%) (Fig. 6D).
Figure 2 Univariate Value of Clinical Parameters, Renal Functio
for the Assessment of Hard Events and Late Revascu
Significant associations were observed between several clinical parameters, includ
events. Similar associations were observed between clinical parameters such as h
*p  0.05; †p  0.01; §p  0.001. CAD  coronary artery disease; DS-MRI  d
Figure 3 Multivariable Value of Clinical Parameters, Renal Func
for the Assessment of Hard Events and Late Revascu
Renal function and baseline ejection fraction were independently associated with h
revascularization procedures. In both models, an abnormal result for myocardial w
§p  0.001. WMA  wall motion abnormalities; other abbreviations as in Figure 2ASELINE EJECTION FRACTION. Excluding patients with
aseline ejection fraction 35% (n  58), an excellent
utcome was observed in 1,149 patients with normal DS-
RI (no cardiac deaths and only 1 nonfatal infarction)
Fig. 6E). Conversely, patients with ejection fraction 35%
ad an increased rate of hard events irrespective of stress
R findings (Fig. 6F).
NFLUENCEOFDIURETICTHERAPYANDHEMODYNAMICRESPONSE.
n patients who received treatment with diuretics, WMA
howed a trend for less robust assessment of future events
aseline MRI, and DS-MRI
tion
nal function and stress magnetic resonance imaging (MRI) findings for hard
nsion, hyperlipidemia, and type 2 diabetes mellitus with late revascularization.
ine stress magnetic resonance imaging.
, Baseline MRI, and DS-MRI
tion
vents. The total number of risk factors, conversely, was associated with late
tion or perfusion was most strongly associated with outcome. *p  0.05;n, B
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Stress MRI for Assessment of Outcome October 5, 2010:1225–34ompared with those who did not receive diuretics
p  0.06 for interaction), whereas no interaction was
bserved for perfusion analysis in this context. On the other
and, assessment of subsequent hard events was similar in
atients with blood pressure increase during DS-MRI
ompared with those with decrease of systemic blood
ressure due to systemic vasodilatation.
bserver Variability
greement between observers interpreting wall motion and
yocardial perfusion was 90% (  0.73) and 93% ( 
.76), respectively for test positivity versus test negativity on
Figure 4 Value of Wall Motion and Perfusion Results
Kaplan-Meier curves for hard events and revascularization-free survival based on w
wall motion abnormalities (WMA) resulted in poorer outcome in patients with and
detection of inducible perfusion deficits added value to the risk stratification only ipatient level. aiscussion
he MR findings presented in our study, in what we believe
o be the largest cohort so far, of 1,493 patients who
nderwent high-dose DS-MRI indicate that: 1) inducible
schemia diagnosed by DS-MRI identifies patients at in-
reased risk for hard events and for late revascularization
rocedures independent of conventional atherogenic risk
actors and of baseline MR findings; 2) myocardial wall
otion and perfusion assessment yielded complementary
iagnostic characteristics. The presence of inducible WMA
as of incremental value for the risk stratification of patients
ith and without inducible perfusion deficits, whereas
erfusion deficits contributed to poorer outcome only in the
tion (A and B) and perfusion test results (C and D). The detection of inducible
t diagnosed inducible perfusion deficits (blue arrows in E and F), whereas the
absence of inducible WMA (red arrow in G).all mo
withou
n thebsence of diagnosed inducible WMA; and 3) a normal
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October 5, 2010:1225–34 Stress MRI for Assessment of Outcometress MRI is prognostically most valuable in patients with
ow or intermediate risk, because patients at high risk still
xhibit a non-negligible rate of subsequent hard events even
n the absence of inducible ischemia.
revious studies. Several findings of our study are consis-
ent with those reported in previous stress studies. Thus,
sing a combined protocol with 2 stressors (adenosine and
obutamine) Jahnke et al. (11) previously reported on the
ncremental prognostic value of stress MRI over clinical
arameters. In another interesting study, dipyridamole
tress MRI also yielded independent information for the
ssessment of cardiac outcome (12). Furthermore, our
atients with inducible WMA exhibited a cardiac event rate
7% to 9% annual rate for cardiac death/nonfatal infarc-
ion), which is very similar to those previously reported by
tress echocardiography and nuclear scintigraphy (13,14).
ethodological aspects and complementary value of
erfusion and wall motion. Previous MR studies used 2
tressors in the same patient, making the test less feasible
nd more time-consuming than stress echocardiography. In
ur study, a single stressor (dobutamine) was used both for
he evaluation of wall motion and perfusion. This protocol
ay be more useful in the clinical routine, particularly with
Figure 5 Complementary Value of Myocardial Perfusion for the
in Patients With Diagnosed Inducible WMA
In patients with diagnosed inducible wall motion abnormalities (WMA), the presenc
subgroups with resting WMA, whereas a trend was noted in this context for patien
(red arrows in B, D, and F versus A, C, and E).igh-volume MR laboratories, due to reduced complexity Mnd lower time spent (25 to 30 min for single stress vs.
45 min for dual stress).
Based on the ischemic cascade, perfusion assessment is
xpected to perform better in ischemia detection, preceding
he development of WMA (1). However, in agreement with
revious studies, the assessment of wall motion during stress
as the most powerful index, yielding the highest hazard
atio for subsequent hard events. Furthermore, the presence
f inducible WMA added value to risk stratification of
atients with and without inducible perfusion deficits.
onversely, the consideration of myocardial perfusion test
esults was useful mainly in the absence of inducible WMA.
mplementing our results in the clinical work flow, the
ollowing algorithm is proposed: if an inducible WMA is
ot seen during a diagnostic DS-MRI procedure, the
dministration of contrast for the evaluation of myocardial
erfusion is recommended. If an inducible WMA is already
etected by cine imaging on the other hand, the value of
dditional perfusion assessment may be limited to patients
ith resting WMA and possibly to those with known CAD
nd LV hypertrophy, where the detection of true positive
nducible WMA may be more challenging (15,16).
Certainly, technical limitations with myocardial perfusion
ssment of Hard Events
dditional perfusion deficits contributed to significantly poorer outcome only in
known coronary artery disease (CAD) and left ventricular (LV) hypertrophyAsse
e of a
ts withR imaging, such as motion artifacts and lower resolution
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Stress MRI for Assessment of Outcome October 5, 2010:1225–34ith increasing heart rates during stress testing, should be
onsidered when interpreting our results. Furthermore, with
ur current perfusion protocol, less myocardium is visualized,
o that ischemia in regions like the apical cap (segment 17) or
he true basal inferior wall may be missed. These shortcom-
ngs, however, may be circumvented in future studies by the
ecent availability of multichannel cardiac coils, which may
llow for 3D first-pass perfusion scans.
linical aspects of survival analysis. By dividing our
atients into those at high risk versus those at low or
ntermediate risk (3), we found that all groups with induc-
ble WMA had a high post-test probability for hard events.
n the other hand, in the absence of inducible WMA, only
atients with low or intermediate risk showed an excellent
ong-term outcome (event-free survival of 99.5%),
hereas patients with high risk still yielded a significant
umber of subsequent hard events (5%). Thus, the value
f a negative stress MR examination may be higher in
atients with low or intermediate risk than in those with
igh risk, which may still experience a considerable rate of
ardiac events despite negative test results. However, even in
atients with known CAD, stress MRI examinations may
Figure 6 Survival Analysis in Patient Subgroups
Kaplan-Meier curves for hard events in patients with low or intermediate versus hi
sorted by pre-test probability (C and D); and in patients with severely versus nonse clinically valuable in order to guide revascularization grocedures in patients with ischemic myocardium (17), as
ecently proposed by the COURAGE (Clinical Outcomes
tilization Revascularization and Aggressive Drug Evalua-
ion) trial substudy (2) (Online Fig. 3).
In addition, in patients without severely impaired LV
unction, no cardiac deaths and only 1 nonfatal myocardial
nfarction were recorded in the latter, in the presence of
ormal DS-MRI, which represents an excellent outcome.
onversely, in patients with severely impaired LV function,
S-MRI test results did not predict outcome beyond the
ssessment of resting LV ejection fraction, which is in
greement with previous observations (18). Simultaneously,
his patient group exhibited increased risk for life-
hreatening complications during imaging.
Interestingly, in patients who received diuretics, WMA
howed a trend for less robust assessment of future events
ompared with those without treatment. Possibly, reduced
V volume in patients treated with diuretics may result in
educed wall stress, diminishing myocardial oxygen con-
umption associated with any given heart rate. This may
revent the development of inducible WMA, weakening
he diagnostic capability of DS-MRI in this patient sub-
(A and B); in patients with versus without inducible WMA
impaired LV function (E and F). Abbreviations as in Figure 5.gh risk
everelyroup.
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October 5, 2010:1225–34 Stress MRI for Assessment of OutcomeFurthermore, it must be noted that since stress test results
ere used to structure treatment, and a great number of
atients underwent early revascularization, the discrimina-
ive power of DS-MRI may be overall underestimated in
ur study.
afety and feasibility aspects. The number of side effects
uring imaging in our study was relatively high, especially in
atients with reduced LV function. This may be attributed
o the high proportion of high-risk patients that were
ncluded. However, the safety profile reported in our study
s similar to that reported in other MR studies and by other
ethodologies using dobutamine infusions (19,20). Fur-
hermore, the real success rate of DS-MRI was relatively
ow (only in 1,510 of 1,784 patients initially screened).
owever, in the absence of general contraindications to
RI or to dobutamine, diagnostic stress examinations were
btained in 1,510 of 1,658 patients (91%). These numbers
re comparable to those reported in previous MRI (19) and
chocardiography (21) studies, where around 10% of pa-
ients will have nondiagnostic results because of an insuffi-
ient hemodynamic response or limiting side effects.
tudy limitations. Our study population arises from a
eferral population at a tertiary care university hospital so
hat a high proportion of high-risk patients was included.
his may limit the extrapolation of our findings to ambu-
atory settings with lower-risk cohorts. Furthermore, wall
otion and perfusion of the myocardium were assessed
isually, which is subjective and depends on the expertise of
he observers. Given the association between myocardial
train response during stress and cardiac outcome (22), and
he ability of strain-encoded MRI techniques to quantify
yocardial strain during stress procedures (23), it would be
seful to investigate the incremental value of strain quanti-
cation with DS-MRI in future trials. Increased LV mass
nd concentric remodeling of the left ventricle were shown
o be important predictors of increased cardiovascular risk in
revious echocardiographic studies (24,25). Furthermore,
ate gadolinium enhancement is a clinically established
echnique for the detection of myocardial infarction and was
ecently shown to predict adverse outcome independent of
egmental WMA (26) or inducible perfusion defects during
tress testing (27). In our study, patterns of LV geometric
emodeling and the presence of delayed enhancement were
ot systematically analyzed, which is a limitation. Such
onditions may have influenced cardiac outcome of individ-
als with high pre-test probability, even in the absence of
ositive stress test results, and merit further investigation in
uture studies. Furthermore, clinicians had access to the
esults of stress testing, which obviously triggered early
evascularization in the majority of patients with inducible
schemia.
onclusions
S-MRI is diagnostic procedure that allows for risk strat-
fication and guides revascularization procedures in patientsith ischemic heart disease. The assessment of wall motion
nd perfusion during stress testing can accurately identify
atients with positive findings who are at increased risk for
ardiac events, and separate them from those with normal
ndings who are at much lower risk. Furthermore, myo-
ardial wall motion and perfusion assessment yielded
omplementary values for the prediction of hard cardiac
vents, whereas a normal stress test was prognostically most
aluable in patients with low or intermediate pre-test
robability and in those with nonseverely impaired baseline
V function.
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